Explore chapters and articles related to this topic
The Twentieth Century and Beyond
Published in Scott M. Jackson, Skin Disease and the History of Dermatology, 2023
Henri Gougerot (1881–1955) was another leading dermatologist in France from the 1920s through the 1950s. Gougerot's name is easily recognized by dermatologists; he described confluent and reticulated papillomatosis and Gougerot-Blum disease, as well as tumid lupus erythematosus. Sjogren syndrome was originally called Gougerot-Sjogren syndrome as Gougerot did some of the initial reporting on that disease. He wrote over 2500 articles and contributed to Darier's eight-volume Nouvelle Pratique Dermatologique. He and Civatte and the next figure, Degos, along with Albert Sezary (1880–1956) and Albert Touraine (1883–1961), all thrived together at Hôpital Saint-Louis in yet another heyday of dermatology at the famous institution.
Clinical examination
Published in Dimitris Rigopoulos, Alexander C. Katoulis, Hyperpigmentation, 2017
Clarissa Prieto Herman Reinehr, Juliano Peruzzo, Tania Cestari
Confluent and reticulated papillomatosis of Gougerot and Carteau (CRP) is a dermatosis of unknown etiology composed of confluent papules in the central area and reticulated papules in the periphery. It typically occurs on the trunk and neck, although some articles describe atypical forms affecting flexural areas.12
Topical ketoconazole: a systematic review of current dermatological applications and future developments
Published in Journal of Dermatological Treatment, 2019
Franchesca D. Choi, Margit L.W. Juhasz, Natasha Atanaskova Mesinkovska
Topical KTZ has been most studied for Malassezia species-related SD and PV, with a clinical efficacy of 63–90% across 21 studies and 71–89% across 7 studies, respectively. Indeed, topical KTZ remains first-line for both diseases in clinical guidelines and reviews published within the last 3 years (13,15,65,66). KTZ is highly lipophilic and concentrates at sites of Malassezia infection, thus increasing treatment efficacy (67). In addition, KTZ also has anti-inflammatory effects by inhibiting 5-lipoxygenase (68), sebum-lowering effects by inhibiting androgenesis (69), and barrier restoring effects by inhibiting keratinocyte hyperproliferation (70). Case reports demonstrate topical KTZ is effective at treating other Malassezia-related diseases such as folliculitis (71–73), confluent and reticulated papillomatosis (74), and neonatal cephalic pustulosis (75). Increased Malassezia colonization is reported in atopic dermatitis (AD) (76–78) and psoriasis (79,80), likely exacerbating disease. There may be a potential role of topical KTZ in the treatment of such inflammatory dermatoses by decreasing Malasseziaburden.
A review of antibiotics and psoriasis: induction, exacerbation, and amelioration
Published in Expert Review of Clinical Pharmacology, 2019
Tetracyclines act on the 30s ribosomal subunit to exert broad-spectrum bacteriostatic effect. Many gram-positive and gram-negative bacteria, Chlamydia, Rickettsia, Mycoplasma, and spirochetes are susceptible to this class of antibiotics. Doxycycline and minocycline are semi-synthetic tetracyclines frequently used in dermatology for rosacea, acne vulgaris, confluent and reticulated papillomatosis, perioral dermatitis, and bullous pemphigoid, probably due to their anti-inflammatory effects.